Health Law Diagnosed: Mintz IRA Update — Q3 2025 Edition
Update: 2025-09-22
Description
In the latest episode of Health Law Diagnosed, Of Counsel Bridgette Keller is joined by Associate Hassan Shaikh for a discussion on noteworthy developments relating to the IRA and drug pricing.
Together, Bridgette and Hassan explore:
- The expansion and evolution of the Medicare Drug Price Negotiation Program
- Court challenges to the Negotiation Program
- Drug pricing reform and the OBBBA
- Impacts on patients and hospitals related to Medicare Part D, 340B, and OPPS clawbacks
- The rise of direct-to-consumer drug sales models
Bridgette and Hassan cut through the complexity and provide an overview of these topics, which are covered in greater depth in the Q3 2025 Edition of the Mintz IRA Update.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
